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The inverted terminal repeat (ITR) of adenovirus type 5 (AdS) is 103 bp in length and contains the origin of
DNA replication. Cellular transcription factors NFI/CTF and NFHVI/OCT-1 bind to sites within the ITR and
participate in the initiation of viral DNA replication in vitro. The ITR also contains multiple copies of two
conserved sequence motifs that bind the cellular transcription factors SP1 and ATF. We have analyzed a series
of viruses that carry deletions at the left terminus of AdS. A virus carrying a deletion of the NFIIHOCT-1, SP1,
and ATF sites within the ITR (mutant d1309-44/107) was wild type for virus growth. However, the deletion of
these elements in addition to sequences immediately flanking the ITR (mutant d1309-44/195) resulted in a virus
that grew poorly. The analysis of growth parameters of these and other mutants demonstrate that the
NFII/OCT-1 and adjacent SP1 sites augment the accumulation of viral DNA following infection. The function
of these elements was most evident in coinfections with a wild-type virus, suggesting that these sites enhance the
ability of a limiting trans-acting factor(s), that stimulates viral DNA replication, to interact with the ITR. The
results of these analyses indicate functional redundancy between different transcription elements at the left
terminus of the Ad5 genome and demonstrate that the NFII/OCT-1 site and adjacent SP1 site, previously
thought to be nonessential for adenovirus growth, play a role in viral DNA replication in vivo.
adenovirus DNA replication, cellular factors NFI and NFIII
are also known to regulate the transcription of viral and
cellular genes; NFI is related to transcription factor CIT
(25), and NFIII is related to the transcription factor OCT-1
(33, 36).
In addition to DNA replication, cis-acting sequences at the
left end of the adenovirus genome direct other events
important for viral growth. The ElA enhancer region, located between nt 195 and 355, is required to stimulate
immediate early transcription of region ElA and is composed of two distinct enhancer elements (21, 22). This region
also contains sequences that are required for packaging of
viral DNA late in infection (12, 13, 20). The ITRs of all
human and simian adenoviruses contain two conserved
sequences: a GC-rich motif and the sequence 5'-TGACGT-3'
(40, 43). While different DNA-binding activities that recognize these sequence motifs have been identified, these elements in AdS have been shown to bind the cellular transcription factors SP1 and ATF (26, 30), respectively, and will be
referred to here as the SP1 and ATF motifs. The adenovirus
ITR possesses promoter and enhancer activities dependent
on these conserved elements (18, 30, 34). Similar sequences
are found between the ITR and the ElA enhancer (nt 104 to
194; Fig. 1). This region also contains binding sites for the
cellular enhancer factors EF-1A (3) and EBP-1 (1) and has
been shown to confer enhancer activity (23). It is likely that
the transcriptional activity of the terminal 195 bp along with
the ElA enhancer is involved in the ElA transcriptional start
sites observed late in infection which initiate as far upstream
as nt 125 (35, 39).
In this report, we examine the phenotype of viral mutants
carrying deletions within and flanking the AdS ITR. Our
results demonstrate that the NFIII/OCI-1 site and adjacent
SP1 site, previously thought to be nonessential for virus
growth, play a role in viral DNA replication in vivo. The

Adenovirus DNA replication requires three viral gene
products: the adenovirus DNA polymerase (Ad Pol), preterminal protein (pTP), and the single-stranded-DNA-binding
protein (DBP) (reviewed in references 4, 42, and 47). Terminal sequence integrity of the linear genome is maintained
by using pTP as a protein primer for DNA replication. pTP
remains covalently attached to the 5' ends of the replicated
DNA and is proteolytically processed to the mature form
late in infection. Adenovirus replication origins are located
at the ends of the genome within the inverted terminal
repeats (ITRs). The adenovirus type 5 (AdS) ITR is 103 bp in
length (Fig. 1); the ITR is 102 bp in Ad2 and is nearly
identical in sequence to the AdS ITR. In vitro studies using
AdS and Ad2 have assigned the replication origin to sequences within the terminal 50 bp (reviewed in references 4,
42). The terminal 18 bp include conserved core sequences
between nucleotides (nt) 9 and 18 that direct low levels of
initiation in vitro. This minimal origin binds the pTP-Ad Pol
complex (31, 46) and the cellular factor ORP-A (38). Maximal origin function in vitro requires the binding sites for the
cellular factors NFI and NFIII located between nt 19 and 50
(Fig. 1) (reviewed in references 4, 42, and 47). These factors
bind noncooperatively to their corresponding sites and stimulate the initiation of replication by different mechanisms
(32). NFI DNA binding is stimulated by DBP (7, 45). NFI
attracts the pTP-Ad Pol replication complex to the origin and
stabilizes its interaction with this region via direct proteinprotein interactions between NFI and Ad Pol (2, 5, 31, 32).
The mechanism of enhancement by NFIII is not clear,
although a role for the bending of DNA induced by NFIII
binding has been postulated (48). In addition to their roles in
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FIG. 1. The left-terminal 194 bp of Ad5. The nucleotide sequence of the Ad5 ITR (terminal 103 bp, indicated by a bracket above the
sequence) and the left-end flanking sequences are shown. Numbers above the sequence represent nucleotide positions relative to the genomic
terminus at nt 1. The stippled oval designates the region protected from DNase I by ORP-A (38). Recognition sequences for cellular factors
NFI/CTF, NFIII/OCT-1, SP1, ATF, EF-1A, and EBP-1 (1, 3, 25, 26, 30, 33, 36) are indicated. Question marks indicate that binding of SP1
or ATF to these binding site homologies has not been determined.

functional role of the NFIII/OCT-1 site could be replaced by
sequences immediately flanking the ITR, suggesting a functional redundancy of these distinct sequences. The phenotype of viruses carrying mutations in the ITR was most
evident in coinfections with a wild-type virus, indicating that
the NFIII site, SP1 site, and elements flanking the ITR
enhance the ability of a limiting trans-acting factor(s), required to augment viral DNA replication, to interact with the
adenovirus terminal repeat. These results suggest that different transcription factors may stimulate the interaction of
such a component with the replication machinery.

MATERLILS AND METHODS
Plasmids and virus constructions. Plasmids used for virus
constructions were derived from pElA-WT, which contains
the left-terminal 1,339 bp of the Ad5 genome cloned into
pBR322 (21). A unique 8-bp BglII linker was inserted in
plasmid pElA-WT at either the RsaI site at nt 194 or the
HphI site at nt 106, generating plasmids pEBL194 and
pEBL106, respectively, which served as parental plasmids
for deletion mutagenesis. Unidirectional deletions that originated at the BglII linker sites and progressed leftward
toward the ITR were constructed by standard cloning procedures using exonuclease III and nuclease Si. An 8-bp
BglII linker was inserted at each deletion endpoint. The
extent of the deletion in each mutant plasmid was determined by nucleotide sequence analysis. The nomenclature of
the plasmids reflects the last nucleotide position remaining at
either side of the deletion junctions; e.g., deletion mutant
pEB44/195 retains nt 44 and 195. Plasmids used to rebuild
viruses d1309-44/195+27 and d1309-44/195+90 were constructed by inserting DNA fragments from different sources
into the BglII linker site of pEB44/195. pEB44/195+27
contains an insertion of a 27-bp synthetic oligonucleotide
carrying the bacteriophage T7 promoter (5'-GATCTCGC
CCTATAGTGAGTCGTATrA-3'). pEB44/195+90 carries
an insertion of a 90-bp fragment that contains five 17-mer
GAL4 binding sites [PstI-XbaI fragment from plasmid
p(GAL4)5/ElBCAT (27)]. All mutations constructed in plasmids were rebuilt into intact viruses by the method of Stow
(44). Virus isolates were screened by restriction endonucle-

ase analysis of viral DNA, and the mutations of the final
virus particle stocks were confirmed by 32P-labeling BglII
restriction fragments with Klenow polymerase and sizing the
left-end fragments in comparison with the parental plasmid
fragment by electrophoresis on a 12% sequencing gel as
previously described (19). Purified virus particles were prepared by CsCl equilibrium gradient sedimentation, titered by
optical density (1 optical density unit at A260 equals 1012
particles), and used for all infections.
Cells, infections, and determination of virus yields. 293 (14)
and HeLa cell lines were maintained as monolayers in
Dulbecco modified Eagle medium containing 10% supplemented calf serum (HyClone). HeLa cells were also propagated in suspension in minimal essential medium containing
5% supplemented calf serum. Virus infections were performed with purified virions at a multiplicity of 200 particles
per cell, except where otherwise indicated, at 37°C for 1 h.
After infection of monolayers, cells were washed twice with
phosphate-buffered saline (PBS) before the addition of fresh
medium. Infected cell lysates were generated by three
freeze-thaw cycles, and infectious virus yields were determined by plaque assays on 293 cells.
Viral DNA accumulation, replication rates, and packaging
efficiency determination. For experiments involving mixed
virus infections, HeLa suspension cells were coinfected with
both mutant and wild-type d1309 viruses as described above.
To assay the accumulation of viral DNA, total nuclear DNA
was isolated at 3, 8, 16, and 24 h postinfection (p.i.). Total
nuclear DNA was isolated by lysing infected cells by the
addition of Nonidet P-40 to 0.4%, harvesting the nuclei by
centrifugation, and isolating DNA as described previously
(28). The isolated DNA was digested with ClaI and BglII, to
distinguish mutant from wild-type DNA, and analyzed by
Southern hybridization (28) using pElA-WT, 32P-labeled by
the random primer method (11), as a probe. Ratios of
wild-type to mutant DNAs were determined by densitometric scanning of autoradiographs generated by using preflashed film. Viral DNA accumulation in the nucleus of
single-virus-infected HeLa monolayer cells was determined
by isolating total nuclear DNA at 3, 8, 12, and 16 h p.i. Viral
DNA in samples of equal amounts of total nuclear DNA was
quantitated by slot blot analysis (49) using a 32P-labeled
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pElA-WT probe as described above. To confirm that equal
amounts of total DNA were represented in all samples,
aliquots were also analyzed with an actin-specific probe
(data not shown). Two different dilutions of samples from a
typical experiment were quantitated by liquid scintillation
spectroscopy of the hybridized filter pieces, and values of
virus-specific counts per minute were normalized to the
input (3-h) value for each virus.
Viral DNA replication rates were determined by [3H]thymidine incorporation into newly synthesized viral DNA.
Infected cells were labeled at 8, 12, and 16 h p.i. for 1 h with
100 ,LzCi of [3H]thymidine per ml. Following the pulse, the
cells were washed twice with PBS, and total nuclear DNA
was isolated, digested with restriction endonuclease HindIII,
fractionated on a 1% agarose gel, and fluorographed. Replication rates at 12 and 16 h p.i. were quantitated by densitometric scanning of virus-specific bands on autoradiograms
from three independent experiments.
To determine the packaging efficiencies of mutant viruses,
HeLa cells coinfected with wild-type and mutant viruses
were harvested at 24 or 48 h p.i., as indicated. Total nuclear
DNA was isolated from one half of the cells, and virion DNA
was isolated from the other half. Virion DNA was isolated as
described previously (12). Briefly, virions were isolated from
cleared lysates of infected cells lysed in 0.2% deoxycholate
and 10% ethanol at pH 9 and then treated with RNase A and
DNase I. Virus particles were lysed in 0.5% sarcosyl, and
the viral DNA was digested with proteinase K, extracted
extensively with phenol-chloroform, and precipitated with
ethanol. Total nuclear and virion DNAs were analyzed by
Southern hybridization as described above.
Detection of viral DBP protein levels. The levels of the E2a
gene product DBP in virus-infected cells were determined by
Western immunoblot analysis (17). Aliquots of infected cells
used for viral DNA replication rate determination were
harvested at 8, 12, and 16 h p.i., and whole cell extracts were
prepared by radioimmunoprecipitation assay lysis as described previously (9). Protein concentrations were determined by using the Bio-Rad protein assay reagent (Bio-Rad
Laboratories). A 50-Rg amount of each sample was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and assayed for relative amounts of DBP by using
clone B6 anti-DBP monoclonal antibody (37), detected by
chemiluminescence with use of ECL Western blotting detection reagents (Amersham).
RESULTS
Viruses with mutations in the NFIII site are defective for
growth. A series of recombinant viruses carrying deletions
which originated at the border of the ElA enhancer and
packaging region at nt 194 and extended leftward toward the
ITR was constructed (Fig. 2A). The growth of these mutant
viruses relative to that of wild-type d1309 was determined by
a one-step growth curve on HeLa and 293 cells (Fig. 2B).
These results showed that functionally redundant elements
important for virus growth are present beyond the terminal
44 bp. Insertion of a BglII linker at nt 194 (d1309-EBL194)
produced a phenotypically wild-type virus. Deletion of sequences between nt 76 and 195 (d1309-76/195) produced a
slightly defective virus which grew to levels within twofold
of the wild-type level. This virus, d1309-76/195, retains one
copy each of the binding sites for cellular transcription
factors NFI/CTF, NFIII/OCT-1, SP1, and ATF. Removal of
the remaining ATF (d1309-60/195) and ATF and SP1 (d130953/195) elements produced viruses that also were slightly
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defective for growth (levels three- to fivefold below the
wild-type level). Mutant virus d1309-44/195 carries a deletion
of sequences between nt 44 and 195 and retains only the NFI
binding site and core origin of replication. This virus grew
very poorly and produced a high percentage of small plaques
in both cell lines. Yields of d1309-44/195 were typically 30- to
50-fold below the wild-type level and varied within this range
among experiments. We attribute this variability in yields to
the inability to detect all of the very small plaques. An
independent mutant isolate, d1309-44/195B, gave similar results. The defect observed with d1309-44/195 in comparison
with dl309-53/195 defines a functional role for NFIII/OCT-1
in vivo. Deletion to nt 36 disrupted the remaining NFI/CTF
site and was lethal in repeated reconstruction experiments.
Insertion of a BglII linker at nt 106, or deletion of the
NFIII/OCT-1, SP1, and ATF motifs within the ITR (sequences between nt 44 and 107) but with maintenance of the
sequences flanking the ITR, produced a virus (dl309-EBL106
or d1309-44/107, respectively) which grew like the wild type
(Table 1) (18, 19).
Viruses carrying insertions of variable size and sequence
in the dl309-44/195 deletion background were constructed to
confirm that the defect observed with dl309-44/195 was
sequence specific and not due to a spacing effect (e.g., with
respect to the packaging sequences). DNA fragments carrying either five binding sites for the yeast transcription factor
GAL4 (90 bp) or the bacteriophage T7 promoter (27 bp) were
inserted into the BglII restriction site of d1309-44/195. The
resulting insertion virus (d1309-44/195+90 or d1309-44/
195+27, respectively) retained the defective growth phenotype of the parental virus (Table 1).
The loss of sequences from the left end of the viral genome
may affect growth of mutant virus d1309-44/195 by perturbing
a number of viral processes; ElA gene expression, viral
DNA replication, and viral DNA packaging are processes
that are directed by left-end sequences. The adenovirus ITR
contains intrinsic promoter and enhancer activities mediated
primarily by the conserved SP1 and ATF motifs (18, 30, 34).
Therefore, expression of ElA in the deletion viruses was
examined. Both the steady-state levels of ElA transcripts
and the utilization of upstream start sites late in infection (35,
39) were unaffected with mutant viruses d1309-76/195, -53/
195, -44/195, and -44/106 (data not shown). In addition, the
growth curves of the mutant viruses were the same in HeLa
and 293 cells (Fig. 2B), which provide the ElA gene products in trans, suggesting that the defects observed were not
at the level of ElA expression.
The NFIII/OCT-1 binding site augments viral DNA replication in vivo. DNA replication of the mutant viruses was
examined in a coinfection assay. In this assay, HeLa cells
were coinfected at equal multiplicities of infection with a
mutant virus and wild-type d1309, which served as a complementing virus for any defect in trans and as an internal
control. Total nuclear DNA was harvested 3 h p.i., before
the onset of viral DNA replication, to determine the input
ratio of mutant to wild-type DNA, and at various time points
after the onset of replication. Ratios of viral DNAs were
determined by Southern hybridization in which mutant DNA
was distinguished from d1309 DNA by restriction endonuclease analysis. The accumulation of mutant relative to wildtype DNA was determined by comparing the ratios at
various time points after replication to the input ratio.
Equivalent amounts of mutant and d1309 DNAs were present
in the nucleus of coinfected cells before the onset of viral
DNA replication, as illustrated by the 3-h time point (Fig. 3).
These input ratios indicated that the virus particle titers were
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FIG. 2. (A) Schematic diagram of mutant viruses. The left-terminal 195 bp of wild-type virus d1309 is shown schematically at the top.
Binding sites within the ITR for cellular transcription factors are indicated as described in the legend to Fig. 1. Thick lines represent deleted
sequences that have been replaced with BglII linkers (white rectangles). EBL194 and EBL106 signify that a BglII linker has been inserted after
nt 194 and 106, respectively; the nomenclature for deletion viruses indicates nucleotide positions remaining at deletion junctions. (B) One-step
growth curves on HeLa and 293 cells. HeLa and 293 cells were infected at a multiplicity of 200 particles per cell. Lysates were harvested at
1, 2, and 3 days p.i., and PFU titers were determined on 293 cells. Titers were determined twice in each of two independent experiments,
and the averaged values are plotted. The one-step growth curves are distinguished by symbols indicated on the right.

correct and that all deletion viruses were able to enter the
cells and deliver their DNA to the nucleus. Virus d1309EBL194 (as well as d1309-44/107; data not shown) produced
the same ratio of wild-type to mutant DNA as the input ratio
during the entire course of infection, thus exhibiting wild-
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TABLE 1. Virus yields with spacing mutants
Virus

d1309-44/195 .......................................
d1309-44/195+90" .......................................
dl309-44/195+27b ............................................
d1309-EBL106 .......................................
d1309-44/107 .......................................

Yieldvaluer
(% of WIT
2.1
1.9
1.6
100
45

a Determined for lysates taken 2 days p.i. in two independent experiments
and expressed as a percentage of the wild-type d1309-EBL194 titer.
b Recombinant virus constructed by the insertion of different-size DNA
fragments into the BgIII linker site of d1309-44/195 as described in the text.

FIG. 3. Accumulation of mutant DNAs in cells coinfected with a
wild-type virus. HeLa cells were coinfected with wild-type d1309
and the indicated mutant viruses each at equal multiplicities. Total
nuclear DNA was prepared at 3, 8, 16, and 24 h p.i. and digested
with ClaI plus BglII. Various dilutions of the digested fragments
were fractionated on a 1% agarose gel, and viral left-end fragments
were detected by Southern hybridization using a probe containing
left-end adenovirus DNA sequences. The migration positions of
mutant and wild-type internal control d1309 fragments are distinguished as indicated. More total DNA was loaded in the 3-h input
samples in order to detect the viral DNA, causing these samples to
run aberrantly.
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FIG. 4. Packaging efficiencies of mutant virus genomes. (A)
Total nuclear (N) and virion (V) DNAs were isolated 48 h after
coinfection of HeLa cells with wild-type d1309 and the indicated
mutant viruses. The samples were analyzed by Southern hybridization as described for Fig. 3. (B) HeLa cells were infected with either
d1309-EBL194 or d1309-44/195 at a multiplicity fivefold higher than
that used for the coinfected wild-type d1309, harvested at 24 h p.i.,
and analyzed for packaging efficiencies as described for panel A.
The input (I) high-molecular-weight nuclear DNA samples harvested at 3 h p.i. are included for comparison.

type kinetics of DNA replication. Nuclear DNA accumulation with mutant d1309-76/195 and -60/195 (data not shown)
was within twofold of that of the coinfected wild-type d1309.
Mutant d1309-53/195 was clearly reduced for DNA accumulation relative to the wild-type virus. Mutant d1309-44/195
was severely defective for DNA accumulation (greater than
20-fold less efficient than d1309) in the coinfection assay.
These results correlate the inability of a given mutant virus
to grow well, as determined by a one-step growth curve with
a defect in viral DNA replication, and show that the defect is
cis acting, since essential gene products required for replication should be provided in trans by the coinfecting wildtype virus.
The left-terminal 380 bp of AdS are involved in viral DNA
packaging (12, 13, 20). This observation prompted us to use
a coinfection assay to test the efficiency with which the
deletion mutant viruses packaged their DNA into virus
particles (Fig. 4). Total nuclear DNA was harvested 48 h
after coinfection of HeLa cells with wild-type and mutant
viruses to determine the nuclear pool of mutant and wildtype DNA available for packaging. This determination was
compared with the ratio of mutant to wild-type DNA that
was productively packaged by analyzing virion DNA from
virus particles isolated at the same time point (Fig. 4). The
ratio of mutant to d1309 DNA available in the nucleus was
correctly reflected in the ratio of DNAs that were actually
packaged into stable virions for all of the deletion mutant
viruses, demonstrating that these viruses packaged their
DNA with wild-type efficiencies. Because the mutant virus
d1309-44/195 replicated so poorly, a fivefold-higher input
ratio of mutant DNA relative to d1309 was used in order to
detect the mutant DNA after 24 h of infection (Fig. 4B).
Unequal ratios of mutant relative to wild-type DNA in the
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nucleus at the time of packaging did not bias the packaging
efficiency of one DNA over the other (d1309-EBL194). These
results showed that mutant d1309-44/195 packaged the low
level of viral DNA that was available in the nuclear pool,
demonstrating the absence of a cis-acting defect in packaging.
The NFIII/OCT-1 binding site stimulates the rate of viral
DNA replication in vivo. The coinfection experiments demonstrated that for the mutant viruses which grew poorly
(d1309-76/195, -60/195, -53/195, and -44/195), the kinetics of
viral DNA accumulation were reduced relative to that of the
coinfected wild-type virus. We next investigated whether
this defect reflected a decrease in the initiation of viral DNA
replication by analyzing DNA replication rates. Singly infected HeLa cells were pulse-labeled for 1 h with [3H]thymidine at 8, 12, and 16 h p.i., and total nuclear DNA was
harvested. Viral DNA was detected by fractionation of
restriction endonuclease digests on an agarose gel and
fluorography. The results of a typical DNA replication rate
experiment are shown in Fig. SA. At the onset of viral DNA
replication (8 h p.i.), no or marginally detectable viral DNA
was evident relative to the smear of labeled cellular DNA. At
12 h p.i., viral DNA as well as partial host DNA replication
shutoff (reduction in background smearing) were evident.
The relative DNA replication rates of d1309-53/195 and
d1309-44/195 were approximately 2.5- and 4-fold below wildtype d1309-EBL194 levels. By 16 h p.i., the shutoff of cellular
DNA replication was complete. The DNA replication of
d1309-53/195 and d1309-44/195 had increased to rates equivalent to and twofold below that of the wild-type virus d1309,
respectively. These data indicate that the mutant viruses
were reduced for the initiation of replication and displayed a
lag in the onset of DNA replication.
Figure 5B shows the results of a Western blot to analyze
the amounts of viral DBP present in the same samples
assayed for DNA replication rates in Fig. SA. The results
indicate that the relative amounts of early gene products
required for viral DNA replication, as measured by DBP,
were equivalent at the onset of viral DNA replication and
were similar during the course of infection for each of the
viruses.
To quantitate the overall DNA replication defect, viral

DNA accumulation in the nucleus of cells infected with
single mutant viruses was determined (Fig. 6). Viral DNA
accumulation in HeLa cells was assayed by slot blot analysis
of total nuclear DNA harvested at 3, 8, 12, or 16 h after
infection with the wild-type and mutant viruses. Viral DNA
accumulation was quantitated by liquid scintillation spectroscopy. The data are plotted in Fig. 6A; the results of a
typical experiment are shown in Fig. 6B. Input levels of
DNA (3 h) were similar in the d1309-53/195 and d1309-44/195
samples relative to the wild-type d1309-EBL194. Over the
time course of the experiment, d1309-53/195 and d1309-44/195
DNA consistently accumulated to levels 1.5 and 2-fold,
respectively, below that of wild-type d1309-EBL194 DNA.
The reduction in mutant d1309-44/195 DNA accumulation
was not due to DNA instability in the nucleus, since mutant
viral DNA was found to be as stable as wild-type DNA as
determined by pulse-chase experiments (data not shown).
These results are consistent with the DNA replication rate
results for these two viruses. The more severe extent of the
cis-acting DNA replication defect observed with d1309-44/
195 in the coinfection assays (Fig. 3 and 4) was likely
exaggerated as a result of competition with the coinfected
wild-type d1309 DNA for a limiting factor(s) required for
DNA replication.
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FIG. 5. Viral DNA replication rates. (A) Autoradiograph of the
fluorographed gel from a typical experiment in which HeLa cells
were infected with the indicated mutant viruses and pulse-labeled
for 1 h with [3H]thymidine at 8, 12, and 16 h p.i. Total nuclear DNA
was harvested, and equal amounts of HindIII-digested total DNA
were subjected to electrophoresis on a 1% agarose gel. (B) Viral
DBP protein levels. Whole cell protein lysates were prepared at 8,
12, and 16 h p.i. from aliquots of the infected cells used for panel A.
Viral DBP-specific bands were detected in samples of equal amounts
of total protein by Western blotting using anti-DBP antiserum.
Mock- and d1309-infected samples were included as controls.

DISCUSSION
The analysis of a series of viral mutants carrying deletions
which impinge on the Ad5 ITR demonstrated that sequences
previously believed to be nonessential for virus viability
contributed in a significant manner to viral growth. Specifically, mutant virus d1309-44/195, which lacks the NFIII/
OCT-1 binding site in the ITR and a series of adjacent,
repeated SP1 and ATF binding motifs and the binding sites
for other transcription factors (Fig. 1), was reduced 30- to
50-fold in yield, as assayed in a single-step growth curve
(Fig. 2B). A second, independently constructed isolate,
d1309-44/195B, displayed the same growth characteristics,
making it unlikely that the defect was due to a fortuitous
second-site mutation. Mutant viruses which maintained the
NFIII/OCT-1 site but lacked the adjacent SP1 and ATF sites
(d1309-53/195, -60/195 and -76/195) also displayed a discernible, although less defective, reduction in virus yield. The
defect in growth in infections with d1309-44/195 was not at
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FIG. 6. Viral DNA accumulation in the nucleus of single-virusinfected cells. HeLa cells were infected with the indicated mutant
viruses, and total nuclear DNA was prepared 3, 8, 12, and 16 h p.i.
Samples containing equal amounts of total DNA were denatured,
and a different dilution for each time point was slot blotted onto a
nitrocellulose membrane. The amount of viral DNA in each sample
was quantitated after Southern hybridization using a left-end adenovirus DNA probe by liquid scintillation spectroscopy of the filter
sections. (A) Results for the experiment shown in panel B, plotted
against the time p.i. that the sample was prepared. After adjustment
for dilution factors, the amount of steady-state viral DNA was
determined as virus-specific counts per minute in the original
sample. (B) Autoradiograph of a typical DNA accumulation experiment, showing total DNA isolated at 3, 8, 12, and 16 h p.i. Controls
included 1.5 ,ug of a mock-infected sample and 125 and 500 pg of
d1309 DNA.

the level of appearance of viral DNA in the nucleus immediately after infection, representing the entry and uncoating
process, since viral DNA accumulation in the nucleus prior
to the onset of viral DNA replication was equivalent to the
wild-type level in coinfection experiments (Fig. 3). The
defect also did not reflect reduced ElA expression (Fig. 2B,
HeLa versus 293, and data not shown) or a lack of any other
virus-encoded trans-acting component, since the defect with
mutant d1309-44/195 was most evident in a coinfection with a
wild-type virus, in which case all necessary products would
be provided in trans (Fig. 3). The packaging of d1309-44/195
DNA into virions was not deficient in coinfection assays
(Fig. 4), indicating that this mutant retained sufficient packaging information in cis. Finally, the reduction in yield with
d1309-44/195 did not reflect a spacing effect due to the
removal of DNA sequences; the insertion of 27 or 90 bp of
heterologous DNA at the deletion junction with this mutant
did not restore wild-type viability (Table 1).
The major defect with d1309-44/195 was found to be at the
level of the rate of viral DNA replication. This represents the
first demonstration that the NFIII/OCT-1 site augments viral
DNA replication in vivo, as has been described in reports of
studies using in vitro replication assays. Coinfection experiments showed a dramatic reduction in the kinetics of viral
DNA accumulation for d1309-44/195 relative to the coinfected wild-type virus d1309 (Fig. 3 and 4). These results
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showed that the DNA replication defect observed was cis
acting. When viral DNA accumulation and replication rates
were determined in single infections (Fig. 5 and 6), the
results showed that both the DNA accumulation and replication rates of d1309-44/195 were reduced but reached levels
within two- to threefold of wild-type levels. The exaggerated
magnitude of the DNA replication defect observed with
d1309-44/195 in the coinfection assay (greater than 20-fold)
was likely due to competition with the coinfected wild-type
virus for a limiting trans-acting factor(s) required to stimulate viral DNA replication.
The growth of d1309-44/195 was rescued by functionally
redundant sequences located in the ITR flanking region
between nt 106 and 195; mutant virus d1309-44/107 and a
similar virus (deletion of Ad2 sequences between nt 45 and
107) described by Hay and McDougall (19) each grew like
the wild type. Redundancy was also evident between the
terminus-distal half of the ITR and the ITR flanking region;
deletion of sequences between either nt 44 and 106 or nt 106
and 195 produced viruses dl309-44/107 and d1309-6 (21),
respectively, which grew like the wild type; however, removal of both blocks of sequences (nt 44 to 195) was
detrimental for the resulting virus d1309-44/195. Sequences
that are similar to the SP1 and ATF motifs, conserved in
multiple copies in the terminus-distal half of the ITR, are
evident in multiple copies in the ITR flanking region (Fig. 1).
We cannot distinguish from these analyses whether these
sites or other regulatory elements in this region contribute to
virus growth. The data strongly indicate that different transcription elements contribute to the level of viral DNA
replication. This functional redundancy may reflect a common mechanism of action.
How does a dramatic 30- to 50-fold decrease in d1309-44/
195 yields come about from a 2- to 3-fold decrease in viral
DNA accumulation? Several points are worth considering.
First, virus yields were determined by plaque assays, and it
is possible that the variability in observed yields for dl30944/195 was due to the inability to detect the unusually high
number of small plaques formed by this mutant. Although
the growth of d1309-44/195 was clearly defective, the yields
may be artificially low because of small plaque size. Consistent with this idea is the fact that mutant dl309-44/195 was
reduced only 5-fold in virus yield in A549 cells (data not
shown), compared with the -50-fold reduction observed in
293 cells (Fig. 2B and Table 1). Larger viral plaques are
produced with A549 cells than with 293 cells, allowing for
more accurate quantitation of virus titers with this mutant
virus. Additionally, the particle-to-PFU ratio for the wildtype virus was -20 on 293 and A549 cells, while that of
mutant d1309-44/195 was -200 on 293 cells and -60 on A549
cells. Second, while postreplication steps in d1309-44/195
virion production appeared normal (late viral protein synthesis was nearly at the wild-type level [data not shown], and no
cis-acting packaging defect was observed when this mutant
was coinfected with wild-type virus [Fig. 4]), the possibility
of a trans-acting defect in viral DNA packaging still remains.
A small RNA has been identified as an essential component
in the packaging of bacteriophage 429 (15, 16). This bacteriophage is similar to adenovirus in genetic structure and
organization. The catalytic packaging sRNA of +29 is encoded by sequences at the left end of the linear doublestranded DNA genome (16) which, as in adenovirus, directs
packaging. Thus, because of the transcriptional competence
of Ad5 left-end sequences (18, 30, 34, 35), expression of such
a putative packaging RNA may have been perturbed with
mutant d1309-44/195, resulting in inefficient packaging in
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singly infected cells. Third, although the levels of mutant
virus DNA in infected cells approached that of the wild type
(Fig. 5), a lag in the onset of replication or a reduction in the
levels of viral DNA accumulation may disrupt the efficient
progression of the virus life cycle. By analogy, adenoviruses
with certain mutations in early region 4 display a lag in viral
DNA accumulation, although wild-type levels are eventually
reached, that results in small plaque size and lower virus
yield (24, 50).
The NFI/CTF and NFIII/OCT-1 binding sites, as well as
the regions which rescue the DNA replication defect of
d1309-44/195 (23, 39), function also as transcription elements.
The use of transcription elements to augment or regulate
origin function is not unprecedented (reviewed in reference
10), and a variety of mechanisms have been described. For
instance, transcription elements can regulate origin function
by forming a promoter. Active transcription in the vicinity of
the Eschenchia coli chromosomal origin (oriC) is required
for initiation of DNA replication in vivo (reviewed in reference 51). In purified replication systems, such transcriptional activation is observed only when oriC melting by
DnaA protein is inhibited by agents which stabilize duplex
formation, e.g., high concentrations of the E. coli histonelike protein HU or low temperatures. Transcriptional activation in this case is mediated by an R loop, formed between
the persistent RNA transcript and the template strand of
DNA, which helps DnaA overcome topological constraints
in unwinding (41). Similarly, transcriptional activation of the
bacteriophage lambda origin is required in vivo and acts to
overcome inhibition by HU in vitro (29). Alternatively, the
site-specific DNA-binding activity of transcription factors
can influence DNA replication initiation. Experiments suggesting that specific binding of NFI/ClF to sites engineered
near the simian virus 40 replication origin stimulated replication by affecting the phasing of nucleosomes such that the
origin remained nucleosome free have been performed (6).
Transcription factors may also influence DNA replication
initiation in a manner similar to the way they are believed to
influence transcription, that is, by interacting with the replication machinery via direct or indirect protein-protein interactions. This is the case for NFI/CTF in adenovirus DNA
replication; direct interactions between NFI/CTF and Ad
Pol are believed to correctly position the viral replication
machinery at the origin (2, 5, 31, 32). Results recently
described by Verrijzer et al. (48) suggest that NFIIIIOCT-1
may stimulate adenovirus DNA replication by the induction
of DNA bending induced by binding at the site. Coenjaerts et
al. have also shown that the spacing of the NFIII/OCT-1 site
relative to the viral terminus is important for activity (8). It
is difficult to understand how sequences outside the ITR are
functionally redundant with the NFIII/OCT-1 site in our
studies, since a linker replaces the NFIII/OCT-1 site in
mutant dl309-44/195 that would be expected to position the
redundant, flanking elements at a distance where NFIII/
OCT-1 does not function in vitro. The observation that the
SP1 site adjacent to the NFIII/OCT-1 site also contributes to
the efficiency of viral DNA replication (d1309-53/195; Fig. 3)
supports the idea that NFIII/OCT-1, SP1, and the redundant
elements between nt 106 and 194 may function similarly to
the NFI/CTF sites when introduced adjacent to the simian
virus 40 origin of replication (6); that is, by blocking the
assembly of chromatin or the binding of other DNA-binding
proteins at the adenovirus terminus, these binding activities
may allow the adenovirus replication complex more ready
access to the viral origin.
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